11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
The DOI matches its Crossref record; 398 of the 412 references it cites were found in a registry or an index.
Abstract
11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) interconverts inactive cortisone and active cortisol. Although bidirectional, in vivo it is believed to function as a reductase generating active glucocorticoid at a prereceptor level, enhancing glucocorticoid receptor activation. In this review, we discuss both the genetic and enzymatic characterization of 11beta-HSD1, as well as describing its role in physiology and pathology in a tissue-specific manner. The molecular basis of cortisone reductase deficiency, the putative "11beta-HSD1 knockout state" in humans, has been defined and is caused by intronic mutations in HSD11B1 that decrease gene transcription together with mutations in hexose-6-phosphate dehydrogenase, an endoluminal enzyme that provides reduced nicotinamide-adenine dinucleotide phosphate as cofactor to 11beta-HSD1 to permit reductase activity. We speculate that hexose-6-phosphate dehydrogenase activity and therefore reduced nicotinamide-adenine dinucleotide phosphate supply may be crucial in determining the directionality of 11beta-HSD1 activity. Therapeutic inhibition of 11beta-HSD1 reductase activity in patients with obesity and the metabolic syndrome, as well as in glaucoma and osteoporosis, remains an exciting prospect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cortisone and prednisone are inactive prohormones that must be reduced to cortisol or prednisolone by hepatic 11HSD1 to bind to and activate the glucocorticoid receptor (GR) (45, 587).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [587]
In the citing paper
“other health outcomes associated with better quality of life improved, including sleep apnoea136 and mobility137.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [136]
In the citing paper
“the glucocorticoid sensitivity may be different among the different individuals and among the different tissues in the same individual, due also to polymorphisms of both glucocorticoid receptor (25)(26)(27)(28) and 11-hydroxysteroid-dehydrogenase type 1 genes (29,30).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [29]
In the citing paper
“HSD11B2 functions exclusively as an oxidative enzyme, inactivating cortisol to cortisone [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
In the citing paper
“while 17OHP and cortisol can be either 5α- or 5β-reduced, 11-deoxycortisol and cortisone are predominantly 5β-reduced [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 1×
“Immunomodulation represents an important facet of glucocorticoid physiology and inflammation therapy and is manifested by the regulation of cytokine production and immune cell function (324).”
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 1×
“Mice overexpressing 11 -HSD1 under the aP2 promoter have enhanced adipocyte differentiation (as measured by increased fat cell size) as a consequence of increased adipose tissue corticosteroid concentrations (139) (see Section VII.”
Short-chain dehydrogenases/reductases (SDR)
Jörnvall, H., Persson, B., Krook, M., Atrian, S., Gonzalez-Duarte, R., Jeffery, J., & Ghosh, D. (1995) · Biochemistry · doi:10.1021/bi00018a001 · Cited by 1,249 · cited 3×
“Also known as short-chain alcohol dehydrogenases (35) or sec (secondary) alcohol dehydrogenases (36), members of this family were originally classified as having 250–300 residues (classical family) with an N-terminal cofactor-binding domain and a centrally located active site, although some enzymes now have more than…”
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Self-citationCole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946 · cited 1×
“Within the fetal rat lung, corticosteroids increased 11-oxoreductase activity, which in turn resulted in an increase in surfactant synthesis (71), a glucocorticoiddependent process (336) essential for normal lung maturation.”
Impaired Energy Homeostasis in C/EBPα Knockout Mice
Wang, N.-D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., & Darlington, G. J. (1995) · Science · doi:10.1126/science.7652557 · Cited by 929
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Self-citationANTI-ESCHERICHIA COLI ALPHA-HAEMOLYSIN IN CONTROL AND PATIENT SERA
Emody, L., Batai, I., Kerényi, M., Székely, J., & Polyak, L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90183-0 · Cited by 800
Research works printed but not linked: 6
- Bush, 1969, 11β-Hydroxysteroid dehydrogenase: contrast between studies in vivo and studies in vitro., Adv Biosci, 3, 23
- Taylor, 1990, Corticosteroid 11-reductase deficiency: steroid studies in a further family, J Clin Invest, 13, P238
- Burtt, 2003, Haplotype-based association studies of HSD11B1 and abdominal obesity, 117
- Bujalska, 2000, Glucocorticoids, 11β-hydroxysteroid dehydrogenase and obesity, 158
- Taylor, 1984, Cortisone reductase deficiency: evidence for a new inborn error in metabolism of adrenal steroids, J Endocrinol, 102, 89
- Savage, 1991, Increased metabolic clearance of cortisol in corticosteroid 11-reductase deficiency, J Endocrinol, 129, 219
Cited by
Items 301–400 of 1,000
Rao, R., & Androulakis, I. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-47605-7 · Cited by 38
Zemanová, L., & Wsól, V. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.638304 · Cited by 43
“Novel inhibitors that seem to be selective for 11β-HSD1 have recently been tested (Draper and Stewart, 2005; Gathercole and Stewart, 2010; Masuzaki and Flier, 2003; Stulnig and Waldhausl, 2004; Tomlinson et al., 2004; Walker and Stewart, 2003; Wamil and Seckl, 2007).”
Bujalska, I. J., Durrani, O. M., Abbott, J. A., Onyimba, C., Khosla, P., Moosavi, A., Reuser, T. T. Q., Stewart, P. M., Tomlinson, J., Walker, E. A., et al. (2007) · Journal of Endocrinology · doi:10.1677/joe-06-0042 · Cited by 47
Self-citationHormone response element binding proteins: Novel regulators of vitamin D and estrogen signaling
Lisse, T. S., Hewison, M., & Adams, J. S. (2011) · Steroids · doi:10.1016/j.steroids.2011.01.002 · Cited by 42
“Target cell responses to steroid/sterol hormones rely on a variety of factors including the expression and regulation of cognate nuclear receptors (1-3), their associated accessory proteins (4) and pre-receptor regulation of the actual hormone ligands (5-6).”
Self-citationRenal medullary 11β-hydroxysteroid dehydrogenase type 1 in Dahl salt-sensitive hypertension
Liu, Y. U., Singh, R. J., Usa, K., Netzel, B. C., & Liang, M. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.90283.2008 · Cited by 42
Cirillo, N., Morgan, D. J., Pedicillo, M. C., Celentano, A., Muzio, L. L., McCullough, M. J., & Prime, S. S. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.243 · Cited by 45
Cortisol Stress Reactivity to the Trier Social Stress Test in Obese Adults
Herhaus, B., & Petrowski, K. (2018) · Obesity Facts · doi:10.1159/000493533 · Cited by 44
The discovery of 2-anilinothiazolones as 11β-HSD1 inhibitors
Yuan, C., Jean, D. J. S., Liu, Q., Cai, L., Li, A., Han, N., Moniz, G. A., Askew, B. C., Hungate, R. W., Johansson, L., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.09.070 · Cited by 44
Isocitrate dehydrogenase: A NADPH-generating enzyme in the lumen of the endoplasmic reticulum
Margittai, É., & Bánhegyi, G. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.12.017 · Cited by 41
Jang, C., Obeyesekere, V. R., Dilley, R. J., Krozowski, Z. S., Inder, W. J., & ALFORD, F. P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2729 · Cited by 46
Kalafatakis, K., Russell, G. M., Ζάρρος, Α., & Lightman, S. L. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.11.009 · Cited by 43
“that locally modulate active GC levels (cortisol conversion to inactive cortisone and vice versa) (Tomlinson et al., 2004), (iv) the capacity of some tissues (for instance the brain) to locally produce/regenerate steroids (Mellon et al.”
Hasenbein, M., Fangue, N. A., Geist, J. P., Komoroske, L. M., & Connon, R. E. (2015) · Aquaculture · doi:10.1016/j.aquaculture.2015.07.005 · Cited by 40
Marcolongo, P., Piccirella, S., Senesi, S., Wunderlich, L., Gerin, I., Mandl, J., Fulceri, R., Bánhegyi, G., & Benedetti, A. (2007) · Endocrinology · doi:10.1210/en.2006-1472 · Cited by 44
Discovery of cyclicsulfonamide derivatives as 11β-hydroxysteroid dehydrogenase 1 inhibitors
Kim, S. H., Ramu, R., Kwon, S. W., Lee, S.-H., Kim, C. H., Kang, S. K., Rhee, S. D., Bae, M. A., Ahn, S. H., Ha, D. C., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.035 · Cited by 39
Lack of Hexose-6-Phosphate Dehydrogenase Impairs Lipid Mobilization from Mouse Adipose Tissue
Bujalska, I. J., Hewitt, K., Hauton, D., Lavery, G. G., Tomlinson, J., Walker, E. A., & Stewart, P. M. (2008) · Endocrinology · doi:10.1210/en.2007-1705 · Cited by 44
Self-citationAndersson, T., Simonyte, K., Andrew, R., Strand, M., Burén, J., Walker, B. R., Mattsson, C., & Olsson, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008475 · Cited by 37
Šimůnková, K., Stárka, L., Hill, M., Kříž, L., Hampl, R., & Vondra, K. (2008) · Physiological Research · doi:10.33549/physiolres.931505 · Cited by 43
Wake, D. J., Stimson, R. H., Tan, G. D., Homer, N. Z. M., Andrew, R., Karpe, F., & Walker, B. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2713 · Cited by 43
Glucocorticoid-Induced Osteoporosis: A Review
Bouvard, B., Legrand, É., Audran, M., & Chappard, D. (2009) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9051-9 · Cited by 40
Moreira, A. C., Antonini, S. R. R., & de Castro, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0102 · Cited by 41
Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease
Petrescu, A. D., Kain, J., Liere, V., Heavener, T. E., & DeMorrow, S. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00660 · Cited by 39
Sun, D., Wang, Z., Di, Y., Jaén, J. C., Labelle, M., Ma, J., Miao, S., Sudom, A. M., Tang, L. V., Tomooka, C. S., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.05.025 · Cited by 38
Constantinopoulos, P., Michalaki, M. A., Kottorou, A. E., Habeos, I. G., Psyrogiannis, A. I., Kalfarentzos, F., & Kyriazopoulou, V. E. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0626 · Cited by 41
Fustinoni, S., Polledri, E., & Mercadante, R. (2013) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.6601 · Cited by 38
Andersson, T., Söderström, I., Šimonytė, K., & Olsson, T. (2010) · Obesity · doi:10.1038/oby.2009.294 · Cited by 41
Li, M., & Leatherland, J. F. (2012) · Fish and Fisheries · doi:10.1111/j.1467-2979.2012.00486.x · Cited by 40
Reduced 11β-hydroxysteroid dehydrogenase type 1 activity in obese boys
Wiegand, S., Richardt, A., Remer, T., Wudy, S. A., Tomlinson, J. W., Hughes, B., Grüters, A., Stewart, P. M., Strasburger, C. J., & Quinkler, M. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0193 · Cited by 37
Self-citationEndogenous glucocorticoids in inflammation: contributions of systemic and local responses
Hardy, R., Raza, K., & Cooper, M. S. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13650 · Cited by 43
Self-citationBaudrand, R., Domínguez, J. M., Carvajal, C. A., Riquelme, A. J., Campino, C., Macchiavello, S. P., Božinović, M., Morales, M., Pizarro, M., Solís, N., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2011.05.001 · Cited by 46
Cerebrospinal fluid dynamics modulation by diet and cytokines in rats
Alimajstorovic, Z., Pascual-Baixauli, E., Hawkes, C. A., Sharrack, B., Loughlin, J., Romero, I. A., & Preston, J. E. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-0168-z · Cited by 37
Alterations of Cortisol Metabolism in Human Disorders
White, P. C. (2018) · Hormone Research in Paediatrics · doi:10.1159/000485508 · Cited by 39
Adiposopathy: treating pathogenic adipose tissue to reduce cardiovascular disease risk
Bays, H., Rodbard, H. W., Schorr, A. B., & González-Campoy, J. M. (2007) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-007-0021-6 · Cited by 36
Lavery, G. G., Hauton, D., Hewitt, K. N., Brice, S. M., Sherlock, M., Walker, E. A., & Stewart, P. M. (2007) · Endocrinology · doi:10.1210/en.2007-0963 · Cited by 43
Self-citationAdrenocortical (dys)function in septic shock - A sick euadrenal state
Venkatesh, B., & Cohen, J. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.04.007 · Cited by 44
Crystal Structures of 11β-Hydroxysteroid Dehydrogenase Type 1 and Their Use in Drug Discovery
THOMAS, M. P., & Potter, B. V. L. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.10.282 · Cited by 40
Youm, J., Park, K., Uchida, Y., Chan, A., Mauro, T. M., Holleran, W. M., & Elias, P. M. (2013) · Wound Repair and Regeneration · doi:10.1111/wrr.12083 · Cited by 36
11β-Hydroxysteroid dehydrogenase 1 contributes to the pro-inflammatory response of keratinocytes
Itoi, S., Terao, M., Murota, H., & Katayama, I. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.09.065 · Cited by 39
Synthesis of Potent and Orally Efficacious 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor HSD-016
Wan, Z.-K., Chenail, E., Li, H.-Q., Kendall, C., Wang, Y., Gingras, S., Xiang, J., Massefski, W. W., Mansour, T., & Saiah, E. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo200958a · Cited by 35
Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia
Chapagain, A., Caton, P., Kieswich, J. E., Andrikopoulos, P., Nayuni, N. K., Long, J. H., Harwood, S., Webster, S. P., Raftery, M., Thiemermann, C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312436111 · Cited by 36
Inherited forms of mineralocorticoid hypertension
Hassan-Smith, Z., & Stewart, P. M. (2011) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283469444 · Cited by 36
Self-citationSelective Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 for Patients With Metabolic Syndrome
Stewart, P. M., & Tomlinson, J. (2008) · Diabetes · doi:10.2337/db08-1404 · Cited by 38
Self-citationMolnár, Á., Kövesdi, A., Szücs, N., Tóth, M., Igaz, P., Rácz, K., & Patócs, A. (2016) · Clinical Endocrinology · doi:10.1111/cen.13022 · Cited by 38
Skalkidou, A., Poromaa, I. S., Iliadis, S. I., Huizink, A. C., Hellgren, C., Freyhult, E., & Comasco, E. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.02.002 · Cited by 36
The Synthesis and Metabolism of Steroid Hormones
Strauss, J. F. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00004-8 · Cited by 40
Harnessing immunomodulation to combat sarcopenia: current insights and possible approaches
Zhang, N., Zhai, L., Wong, R. M. Y., Cui, C., Law, S. W., Chow, S. K., Goodman, S. B., & Cheung, W. (2024) · Immunity & Ageing · doi:10.1186/s12979-024-00458-9 · Cited by 40
“IL-6 IL-6 and TNF-α can induce the age-related upregulation of 11βHSD1 based on in vitro investigations involving humans and rodents [45], thereby amplifying the synthesis of cortisol and contributing to muscle catabolism in sarcopenia [46].”
Spontaneous Miscarriages Are Explained by the Stress/Glucocorticoid/Lipoxin A4 Axis
Xu, Z., Zhao, J., Zhang, H., Tang, K., Xu, P., Cai, W., Katirai, F., Ye, D., Huang, Y., & Huang, B. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202807 · Cited by 37
Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension
Westgate, C. S. J., Markey, K. A., Mitchell, J., Yiangou, A., Singhal, R., Stewart, P. M., Tomlinson, J., Lavery, G. G., Mollan, S. P., & Sinclair, A. J. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0108 · Cited by 36
Self-citationBensreti, H., Alhamad, D. W., Marrero‐Gonzalez, A. R., Pizarro-Mondesir, M., Bollag, W. B., Isales, C. M., & McGee‐Lawrence, M. E. (2022) · Current Osteoporosis Reports · doi:10.1007/s11914-022-00772-5 · Cited by 33
Cohen, J., & Venkatesh, B. (2010) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1003800304 · Cited by 36
Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?
Majumdar, S. K., & Inzucchi, S. E. (2013) · Endocrine · doi:10.1007/s12020-013-9884-3 · Cited by 39
Pierotti, S., Gandini, L., Lenzi, A., & Isidori, A. M. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.09.018 · Cited by 37
Takeshita, Y., Watanabe, S., Hattori, T., Nagasawa, K., Matsuura, N., Takahashi, K., Murohara, T., & Nagata, K. (2015) · Hypertension Research · doi:10.1038/hr.2015.77 · Cited by 34
Sakamuri, S. S. V. P., Sukapaka, M., Prathipati, V. K., Nemani, H., Putcha, U. K., Pothana, S., Koppala, S. R., Ponday, L. R. K., Acharya, V., Giridharan, N. V., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050216 · Cited by 33
“It is expressed in various tissues including liver, adipose tissue and brain [2].”
Robic, A., Fève, K., Louveau, I., Riquet, J., & Prunier, A. (2015) · Animal Science Journal · doi:10.1111/asj.12532 · Cited by 34
Rosiglitazone decreases 11β‐hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue
Mai, K., Andres, J., Bobbert, T., Maser‐Gluth, C., Möhlig, M., Bähr, V., Pfeiffer, A. F. H., Spranger, J., & Diederich, S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02903.x · Cited by 36
Xiang, J. S., Wan, Z., Li, H., Ipek, M., Binnun, E., Nunez, J., Chen, L.-R., McKew, J. C., Mansour, T. S., Xu, X., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8004948 · Cited by 35
Replacement therapy for Addison's disease: recent developments
Løvås, K., & Husebye, E. S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.4.497 · Cited by 32
“Furthermore, unbound cortisone circulates at concentrations similar to peak free cortisol, which provides a substrate for cortisol regeneration in peripheral tissues that express the enzyme 11 β -hydroxysteroid dehydrogenase type 1 (11 β -HSD1) [46,47] .”
InfluentialKim, S. Y., Nguyen, A. D., Gao, J., Murphy, P. M., Mansfield, B. C., & CHOU, J. Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604964200 · Cited by 33
Torrecilla, E., Fernández‐Vázquez, G., Vicent, D., Sánchez‐Franco, F., Barabash, A., Cabrerizo, L., Sánchez-Pernaute, A., Torres, A. J., & Rubio, M. Á. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0524-9 · Cited by 35
Ritter, H. D., & Mueller, C. R. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-275 · Cited by 34
Chan, J., Rabbitt, E. H., Innes, B. A., Bulmer, J. N., Stewart, P. M., Kilby, M. D., & Hewison, M. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0289 · Cited by 34
“In contrast to the type 2 isozyme, 11b-HSD1 can catalyze both dehydrogenase (cortisol inactivation) and reductase (cortisol synthesis) activities, although in most tissues the latter predominates (Tomlinson et al. 2004).”
Self-citationPatel, H., Dhangar, K., Sonawane, Y. A., Surana, S. J., Karpoormath, R. V., Thapliyal, N. B., Shaikh, M. S., Noolvi, M. N., & Jagtap, R. (2015) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2015.08.003 · Cited by 36
Lee, S. E., Kim, J.-M., Jeong, M.-K., Zouboulis, C. C., & Lee, S. H. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12009 · Cited by 32
Dovio, A., Sartori, M. L., Francia, S. D., Mussino, S., Perotti, P., Saba, L., Abbadessa, G., Racca, S., & Angeli, A. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.04.007 · Cited by 32
Characterization of a Novel Oral Glucocorticoid System and Its Possible Role in Disease
Cirillo, N., Hassona, Y. M., Pignatelli, M., Gasparoto, T. H., Morgan, D. J. W., & Prime, S. S. (2011) · Journal of Dental Research · doi:10.1177/0022034511427909 · Cited by 33
Pelletier, G., Luu-The, V., Li, S., Bujold, G., & Labrie, F. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.038 · Cited by 32
The cardioprotective effects of mineralocorticoid receptor antagonists
van den Berg, T. N. A., Rongen, G. A. P. J. M., Fröhlich, G., Deinum, J., Hausenloy, D. J., & Riksen, N. P. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.006 · Cited by 33
Djordjevic, A. D., Bursać, B. N., Veličković, N. A., Teofilović, A., & Matić, G. M. (2013) · Nutritional Neuroscience · doi:10.1179/1476830513y.0000000098 · Cited by 32
Li, X., Lindquist, S., Chen, R., Myrnäs, T., Angsten, G., Olsson, T., & Hernell, O. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803470 · Cited by 37
Impact of Acute and Chronic Low-Dose Glucocorticoids on Protein Metabolism
Burt, M. G., Johannsson, G., Umpleby, A. M., Chisholm, D. J., & Ho, K. K. Y. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0951 · Cited by 35
Glucocorticoid metabolism in the developing lung: adrenal-like synthesis pathway
Provost, P. R., Boucher, E., & Tremblay, Y. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.03.004 · Cited by 31
“11-HSD1 is expressed in many tissues [66] including the fetal lung in the mouse [67-69], rat [70], and sheep [71].”
Autophagic Degradation of Collagen 1A1 by Cortisol in Human Amnion Fibroblasts
Mi, Y., Wang, W., Zhang, C., Liu, C., Lu, J., Li, W., Zuo, R., Myatt, L., & Sun, K. (2017) · Endocrinology · doi:10.1210/en.2016-1829 · Cited by 31
Zhukouskaya, V. V., Eller-Vainicher, C., Gaudio, A., Cairoli, E., Ulivieri, F. M., Palmieri, S., Morelli, V., Orsi, E., Masserini, B., Barbieri, A. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4177 · Cited by 32
Novel non-steroidal inhibitors of human 11β-hydroxysteroid dehydrogenase type 1
Vicker, N., Su, X., Ganeshapillai, D., Smith, A., Purohit, A., Reed, M. J., & Potter, B. V. L. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.03.023 · Cited by 31
Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy
Dineen, R., Stewart, P. M., & Sherlock, M. (2019) · Clinical Endocrinology · doi:10.1111/cen.13837 · Cited by 30
Self-citationKovačević, S., Brkljačić, J. M., Matić, G. M., & Elaković, I. (2014) · European Journal of Nutrition · doi:10.1007/s00394-013-0644-1 · Cited by 33
“This glucocorticoid regulation, called ‘‘prereceptor cortisol metabolism,’’ is based on the intracellular regeneration of active glucocorticoids (cortisol in humans and corticosterone in rodents) by the microsomal enzyme 11bhydroxysteroid dehydrogenase type 1 (11bHSD1) [11].”
Boothby, M., McGee, K. C., Tomlinson, J., Gathercole, L., McTernan, P. G., Shojaee‐Moradie, F., Umpleby, A. M., Nightingale, P., & Shahmanesh, M. (2009) · Antiviral Therapy · doi:10.3851/imp1457 · Cited by 30
“Genes involved in glucocorticoid generation, essential for adipocyte differentiation were 11β-hydroxysteroid dehydrogenase type-1 (11βHSD-1), which regenerates the active glucocorticoid cortisol from inactive cortisone [11]; hexose 6-phosphate dehydrogenase (H6PDH), which generates the cofactor NADPH for 11βHSD-1 and…”
Self-citationTerao, M., Itoi, S., Murota, H., & Katayama, I. (2012) · Experimental Dermatology · doi:10.1111/exd.12075 · Cited by 35
Edgerton, D. S., Basu, R., Ramnanan, C. J., Farmer, T. D., Neal, D. W., Scott, M. F., Jacobson, P. B., Rizza, R. A., & Cherrington, A. D. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00740.2009 · Cited by 30
Schutten, J. C., Joris, P. J., Minović, I., Post, A., van Beek, A. P., de Borst, M. H., Mensink, R. P., & Bakker, S. J. L. (2020) · Clinical Endocrinology · doi:10.1111/cen.14350 · Cited by 31
Controversies surrounding critical illness‐related corticosteroid insufficiency in animals
Burkitt, J. M. (2014) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12270 · Cited by 30
Cardiovascular and Metabolic Impact of Glucocorticoid Replacement Therapy
Johannsson, G., & Ragnarsson, Ó. (2014) · Frontiers of hormone research · doi:10.1159/000360556 · Cited by 36
Kawai, M., Kusuda, S., Cho, K., Horikawa, R., Takizawa, F., Ono, M., Hattori, T., & Oshiro, M. (2011) · Pediatrics International · doi:10.1111/j.1442-200x.2011.03518.x · Cited by 31
Liu, X., Xie, B., Wang, Z., Jin, L., & Zhang, Y. (2016) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2016.03.009 · Cited by 32
Dammann, C., Stapelfeld, C., & Maser, E. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.02.018 · Cited by 30
Rew, Y., McMinn, D. L., Wang, Z., He, X., Hungate, R. W., Jaén, J. C., Sudom, A. M., Sun, D., Tu, H., Ursu, S., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.058 · Cited by 30
Jang, C., Obeyesekere, V. R., Dilley, R. J., Alford, F. P., & Inder, W. J. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02669.x · Cited by 30
Veyrat‐Durebex, C., Deblon, N., Caillon, A., Andrew, R., Altirriba, J., Odermatt, A., & Rohner‐Jeanrenaud, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034002 · Cited by 33
“This might represent the establishment of a partial compensatory mechanism aimed at resisting hyperglycemia [10] by increasing local insulin sensitivity [58].”
The glucocorticoid receptor in osteoprogenitors regulates bone mass and marrow fat
Pierce, J. L., Ding, K.-H., Xu, J., Sharma, A. K., Yu, K., del Mazo Arbona, N., Rodríguez-Santos, Z., Bernard, P. J., Bollag, W. B., Johnson, M. H., et al. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0230 · Cited by 30
“2010, Weinstein 2012).”
Nakayama, J., Lu, J., Makinoshima, H., & Gong, Z. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0759 · Cited by 30
Ravisankar, S., Hanna, C. B., Brooks, K. E., Murphy, M. J., Redmayne, N., Ryu, J., Kinchen, J. M., Chavez, S. L., & Hennebold, J. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-85704-6 · Cited by 29
Hu, A., Fatma, S., Cao, J., Grunstein, J. S., Niño, G., Grumbach, Y., & GRUNSTEIN, M. M. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90572.2008 · Cited by 29
Siggelkow, H., Etmanski, M., Bozkurt, S., Groβ, P., Koepp, R., Brockmöller, J., & Tzvetkov, M. V. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1418 · Cited by 29
Cuzzola, A. R., Mazzini, F., & Petri, A. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.02.003 · Cited by 29
Zhu, L., Hou, M., Sun, B., Burén, J., Zhang, L., Yi, J., Hernell, O., & Li, X. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2708 · Cited by 32
Glucocorticoid-Induced Bone Fragility Is Prevented in Female Mice by Blocking Pyk2/Anoikis Signaling
Sato, A. Y., Cregor, M. D., McAndrews, K., Li, T., Condon, K. W., Plotkin, L. I., & Bellido, T. (2019) · Endocrinology · doi:10.1210/en.2019-00237 · Cited by 29
Renal interstitial corticosterone and 11-dehydrocorticosterone in conscious rats
Usa, K., Singh, R., Netzel, B. C., Liu, Y., Raff, H., & Liang, M. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00484.2006 · Cited by 30
The importance of glucocorticoid receptors in systemic lupus erythaematosus. A systematic review
Bazsó, A., Szappanos, Á., Patócs, A., Poór, G., Shoenfeld, Y., & Kiss, E. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.12.007 · Cited by 28
Butterflies in the gut: the interplay between intestinal microbiota and stress
Lai, T.-T., Liou, C.-W., Tsai, Y.-H., Lin, Y.-Y., & Wu, W. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00984-6 · Cited by 29
Expression of 11β‐Hydroxysteroid Dehydrogenase Type 1 in the Human Hypothalamus
Bisschop, P. H., Dekker, M. J. H. J., Osterthun, W., Kwakkel, J., Anink, J. J., Boelen, A., Unmehopa, U. A., Koper, J. W., Lamberts, S. W. J., Stewart, P. M., et al. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12017 · Cited by 29
Self-citation
Metadata
- Authors
- Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-10-01
- Volume
- 25
- Issue
- 5
- Pages
- 831-866
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2016125985
- Semantic Scholar
- 7653c899826b606d61172864887c634e9d76851b
- Cited by
- 969
- References
- 412
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 25 · 2023: 23 · 2022: 32 · 2021: 30 · 2020: 27 · 2019: 34 · 2018: 30 · 2017: 33 · 2016: 38 · 2015: 43 · 2014: 55 · 2013: 65 · 2012: 70
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, glucocorticoid metabolism, hexose-6-phosphate dehydrogenase, NADPH cofactor, tissue-specific gene regulation, obesity, metabolic syndrome, glaucoma, osteoporosis, 11β-HSD1 inhibition
- MeSH terms
- Amino Acid Sequence, Animals, Carbohydrate Dehydrogenases, Cloning, Molecular, Cortisone Reductase, Enzyme Inhibitors, Glaucoma, Glucocorticoids, Humans, Hydrocortisone, Molecular Sequence Data, Mutation, NADP, Obesity, Organ Specificity, Osteoporosis, Recombinant Proteins, Substrate Specificity, Transcription, Genetic, Gene Expression Regulation, Enzymologic, Sequence Alignment, 11-beta-Hydroxysteroid Dehydrogenase Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.